Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605783 · ClinicalTrials.gov registry record · NA
Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel
A NA study, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- Completed
- Registry status
- NA
- Development phase
- 851
- Enrollment target
NCT04605783 is a NA study that has completed, run by Henry M. Jackson Foundation for the Advancement of Military Medicine. The registered enrollment target is 851 participants.
The verdict
NCT04605783, a NA study, has completed, sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 851 participants
- Enrollment target
Study Summary
Passive immunoprophylaxis is a class of dietary supplements that is lawfully marketed in the US for maintenance of gut health (GH). This randomized, double-blind, clinical trial will evaluate passive immunoprophylaxis (Travelan®) product compared with placebo, to assess the ability to maintain normal gut function during travel. The results of this clinical trial will be used to evaluate the use of a dietary supplement to maintain GH during deployment and travel and is not intended to support a marketing application of any dietary supplement as a drug or biological product for human use.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Travelan®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 851 participants |
| Start Date | 2022-05-27 |
| Est. Completion | 2025-06-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04605783
The ClinicalTrials.gov registry entry for NCT04605783 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 851 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04605783 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04605783 about?
NCT04605783 is a clinical study titled "Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel". Passive immunoprophylaxis is a class of dietary supplements that is lawfully marketed in the US for maintenance of gut health (GH). This randomized, double-blind, clinical trial will evaluate passive immunoprophylaxis (Travelan®) product compared with placebo, to assess the ability to maintain norma...
What is the current status of trial NCT04605783?
This trial is currently completed. It is a NA study. The enrollment target is 851 participants. The study started on 2022-05-27. Estimated completion is 2025-06-20.
What interventions are being tested in trial NCT04605783?
The interventions under investigation include: Placebo (OTHER), Travelan® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04605783?
This trial is sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.